Skip to main content
. 2023 May 15;8(6):1051–1063. doi: 10.1038/s41564-023-01389-9

Extended Data Fig. 8. Sensitivity to anti-hACE2 antibodies after rVSV/SARS-CoV-2/GFP replication in the presence of anti-hACE2 antibodies.

Extended Data Fig. 8

(A, B) Infectious virus yield after rVSV/SARS-CoV-2/GFP replication for 2 passages (A) or 4 passages (B) in the presence of each of four anti-hACE2 antibodies, or the anti-RBD antibody C144. The concentrations (in μg/ml) indicated on the X-axis or in the absence of antibody (No). Data are derived from two independent experiments. (C) Inhibition of HIV-1 based pseudotyped virus infection by anti-hACE2 mAbs. Anti-hACE2 antibodies (05H02, 2G7A1, 05B04 and the hybrid antibody 05B04 LC/05D06 HC) were incubated with Huh-7.5 target cells and cells were infected with pseudotypes bearing WT or Q498H spike proteins. Infection was measured using NanoLuc luciferase assays. Mean of two independent titrations is plotted, and IC50 values for each anti-hACE2 antibody virus combination is given below.

Source data